ingrid_STO said:Financial impact of cost and coverage weight loss beyond medication cost: Groceries: SAVED $273/month (eating less) Restaurants: SAVED $203/month…
Insurance update relevant to cost and coverage: I just got my prior auth approved through Cigna after 1 attempts.
What finally worked: a letter from my endocrinologist documenting BMI history (>3 years), failed diet attempts, comorbidities (PCOS + insulin resistance), and referencing the SURMOUNT trial data.
If your PA keeps getting denied, don't give up. Request a peer-to-peer review between your doctor and the insurance medical director. That's what finally broke through for me.
A narrower follow-up, since the general answer is now clear:
What a vetting checklist should actually contain, as opposed to a list of things that are easy to fake?
lisa_labSD said:Insurance update relevant to cost and coverage: I just got my prior auth approved through Cigna after 1 attempts.
My insurance denied my PA related to cost and coverage. Has anyone successfully appealed? I'm considering going compounded instead.
Janoshik Analytical — Independent Testing
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesGL Biochem (Shanghai) Ltd. — Direct Manufacturer
Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL Biochemlisa_labSD said:Insurance update relevant to cost and coverage: I just got my prior auth approved through Cigna after 1 attempts.
lisa_labSD said:...regarding the discontinuation data for cost and coverage...
I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."
Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.
This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.
lisa_labSD said:Insurance update relevant to cost and coverage: I just got my prior auth approved through Cigna after 1 attempts.
This answered a question I did not know how to ask. I will report back once I have actually tried it.